Media Summary: In this webinar, Prof Harald Mischak present his work and is joined in discussion by Prof Donald Jones and Prof Alicia Lundby. With researchers touting recent success in sequencing the human genome's remaining gaps, an emerging frontier is How do we know if you're having a heart attack? What are these biomarkers blood tests look for? They're proteins. The

Proteomics Cardiovascular Proteomics - Detailed Analysis & Overview

In this webinar, Prof Harald Mischak present his work and is joined in discussion by Prof Donald Jones and Prof Alicia Lundby. With researchers touting recent success in sequencing the human genome's remaining gaps, an emerging frontier is How do we know if you're having a heart attack? What are these biomarkers blood tests look for? They're proteins. The Merry Lindsey, PhD, lead author, announces the publication of "The Transformative Impact of This presentation, presented on Tuesday, October 1st, 2024 was part of the 2024 Ted Rogers Centre Heart Failure Symposium. Professor Don Jones from University of Leicester presents at IMSC 2018. Learn about Novel Strategies for Discovery of ...

Atherosclerosis can result in severe outcomes, including heart attack and stroke. The presence of atherosclerotic plaques is one ... Presented by M Mayr (London, GB) at ESC Basic Science Summer School 2019.

Photo Gallery

Proteomics: Cardiovascular Proteomics
Proteomics in Cardiovascular Research
Proteomics 101
The Proteome | Precision Health at Cedars-Sinai
The Transformative Impact of Proteomics on Cardiovascular Health and Disease
Proteomic Prediction of Cardiovascular (CV) Risk, Sensitive to Change in Outcomes
Dr. Jennifer Van Eyk - What Have We Learned from Cardiac Proteomics?
The Utility of Plasma Proteomics in Precision Medicine
Using proteomics to predict heart disease risk
Proteomics Heart Disease Jennifer Van Eyk, Ph.D. | Cedars-Sinai
Genomics Data & Insights into Cardiovascular Disease by Dr. Robert Gerszten (BIDMC)
Proteomics and Cardiovascular Biomarkers | Mark McComb, PhD, BU Medical Center
View Detailed Profile
Proteomics: Cardiovascular Proteomics

Proteomics: Cardiovascular Proteomics

In this webinar, Prof Harald Mischak present his work and is joined in discussion by Prof Donald Jones and Prof Alicia Lundby.

Proteomics in Cardiovascular Research

Proteomics in Cardiovascular Research

Genomic medicine is coming to

Proteomics 101

Proteomics 101

With researchers touting recent success in sequencing the human genome's remaining gaps, an emerging frontier is

The Proteome | Precision Health at Cedars-Sinai

The Proteome | Precision Health at Cedars-Sinai

How do we know if you're having a heart attack? What are these biomarkers blood tests look for? They're proteins. The

The Transformative Impact of Proteomics on Cardiovascular Health and Disease

The Transformative Impact of Proteomics on Cardiovascular Health and Disease

Merry Lindsey, PhD, lead author, announces the publication of "The Transformative Impact of

Proteomic Prediction of Cardiovascular (CV) Risk, Sensitive to Change in Outcomes

Proteomic Prediction of Cardiovascular (CV) Risk, Sensitive to Change in Outcomes

Presentation Title:

Dr. Jennifer Van Eyk - What Have We Learned from Cardiac Proteomics?

Dr. Jennifer Van Eyk - What Have We Learned from Cardiac Proteomics?

This presentation, presented on Tuesday, October 1st, 2024 was part of the 2024 Ted Rogers Centre Heart Failure Symposium.

The Utility of Plasma Proteomics in Precision Medicine

The Utility of Plasma Proteomics in Precision Medicine

Professor Don Jones from University of Leicester presents at IMSC 2018. Learn about Novel Strategies for Discovery of ...

Using proteomics to predict heart disease risk

Using proteomics to predict heart disease risk

Atherosclerosis can result in severe outcomes, including heart attack and stroke. The presence of atherosclerotic plaques is one ...

Proteomics Heart Disease Jennifer Van Eyk, Ph.D. | Cedars-Sinai

Proteomics Heart Disease Jennifer Van Eyk, Ph.D. | Cedars-Sinai

Description.

Genomics Data & Insights into Cardiovascular Disease by Dr. Robert Gerszten (BIDMC)

Genomics Data & Insights into Cardiovascular Disease by Dr. Robert Gerszten (BIDMC)

BIDMC's Dr. Robert Gerszten, Chief of

Proteomics and Cardiovascular Biomarkers | Mark McComb, PhD, BU Medical Center

Proteomics and Cardiovascular Biomarkers | Mark McComb, PhD, BU Medical Center

Prof. Mark E. McComb, PhD from the

The advantages and limitations of proteomics and metabolomics

The advantages and limitations of proteomics and metabolomics

Presented by M Mayr (London, GB) at ESC Basic Science Summer School 2019.